Pursuant to Regulation 30 and 33 of SEBI (Listing Obligation and Disclosure Requirements) 2015 we wish to inform you that the Board of Directors at its meeting held today has considered and approved the un-audited financial results (consolidated and standalone) as per Indian Accounting Standard (Ind-AS) along with Limited Review Report for the quarter and half year ended September 30 2019. A copy of the un-audited financial results along with the Limited Review Report is enclosed herewith.
The above information will also be available on the website of the Company at www.biocon.com.
Further the Board Meeting commenced at 1:30 pm and concluded at 6:00 pm.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
